Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.

Kelly G PaulsonVinod RaviBrian P RubinMin ParkElizabeth T LoggersLee D Cranmer Michael J Wagner

Published in: Cancer medicine (2023)

Malignant hemangioendothelioma is ultra-rare but meaningfully impacts affected patients. These data may provide benchmarks for comparison of new approaches to hemangioendothelioma therapy and highlight poor survival outcomes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
prognostic factors
machine learning
high resolution
big data
stem cells
mass spectrometry
patient reported outcomes
bone marrow
patient reported
data analysis